# CORRESP — CRESCENT BIOPHARMA, INC.  (CBIO)  (CIK 0001253689)

> <strong>CRESCENT BIOPHARMA, INC.  (CBIO)  (CIK 0001253689) → SEC staff</strong> · filed 2026-01-13 · ticker CBIO · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001628280-26-001951
- **Form:** CORRESP
- **Filer:** CRESCENT BIOPHARMA, INC.  (CBIO)  (CIK 0001253689)
- **CIK:** 0001253689
- **Ticker:** CBIO
- **Filed:** 2026-01-13
- **SIC industry:** 2834
- **HQ:** Waltham, MA

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1253689/000162828026001951/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1253689&type=UPLOAD&dateb=&owner=include&count=40

## Other comment-letter activity for CRESCENT BIOPHARMA, INC.  (CBIO)  (CIK 0001253689)

- UPLOAD — 2026-01-12 — /comment-letter/0000000000-26-000353

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, CRESCENT BIOPHARMA, INC.  (CBIO)  (CIK 0001253689) (CIK 0001253689), filed 2026-01-13, accession 0001628280-26-001951. Retrieved via MORVS 2026-11-04 from https://api.morvs.ai/comment-letter/0001628280-26-001951.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*